ELEV Elevate plans to begin activating trial accounts as soon as September 2012 . The company has expanded relationships with technology partners and has acquired proprietary intellectual property, which is being used to complete the development of Serifym. "We recognize the need to expand our current offerings to include protection for emerging threats to the family. It is a part of our core values as a company to be actively engaged in developing new solutions for old problems and new threats," said Wright Thurston , CEO.
over $25k traded here. Nice numbers given how unknown this one typically is. You have to think that a Q or 2 more and we the market will reward shareholders for such continued topline growth.
News 
Market Data 
Discover 
